These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


335 related items for PubMed ID: 16546323

  • 1. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties.
    Biasco G, Derenzini E, Grazi G, Ercolani G, Ravaioli M, Pantaleo MA, Brandi G.
    Cancer Treat Rev; 2006 May; 32(3):214-28. PubMed ID: 16546323
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y.
    J Clin Oncol; 2005 Aug 01; 23(22):4888-96. PubMed ID: 16009951
    [Abstract] [Full Text] [Related]

  • 6. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases.
    Allard MA, Malka D.
    J Visc Surg; 2014 Apr 01; 151 Suppl 1():S21-4. PubMed ID: 24636278
    [Abstract] [Full Text] [Related]

  • 7. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
    Tanaka K, Nojiri K, Kumamoto T, Takeda K, Endo I.
    Eur J Surg Oncol; 2011 Apr 01; 37(4):336-43. PubMed ID: 21277151
    [Abstract] [Full Text] [Related]

  • 8. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D.
    BMC Cancer; 2018 Aug 06; 18(1):787. PubMed ID: 30081865
    [Abstract] [Full Text] [Related]

  • 9. Management of liver metastases from colorectal cancer.
    Kemeny N.
    Oncology (Williston Park); 2006 Sep 06; 20(10):1161-76, 1179; discussion 1179-80, 1185-6. PubMed ID: 17024869
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
    Sahajpal A, Vollmer CM, Dixon E, Chan EK, Wei A, Cattral MS, Taylor BR, Grant DR, Greig PD, Gallinger S.
    J Surg Oncol; 2007 Jan 01; 95(1):22-7. PubMed ID: 17066435
    [Abstract] [Full Text] [Related]

  • 11. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D.
    Ann Surg; 2010 Apr 01; 251(4):686-91. PubMed ID: 20224373
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatic metastases of colorectal cancer: locoregional intra-arterial treatment.
    Pasetto LM, Merenda R, Pilati P, Sinigaglia G, Monfardini S.
    Anticancer Res; 2006 Apr 01; 26(6C):4785-92. PubMed ID: 17214342
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
    Lévi FA, Boige V, Hebbar M, Smith D, Lepère C, Focan C, Karaboué A, Guimbaud R, Carvalho C, Tumolo S, Innominato P, Ajavon Y, Truant S, Castaing D, De Baere T, Kunstlinger F, Bouchahda M, Afshar M, Rougier P, Adam R, Ducreux M, Association Internationale pour Recherche sur Temps Biologique et Chronothérapie (ARTBC International).
    Ann Oncol; 2016 Feb 01; 27(2):267-74. PubMed ID: 26578731
    [Abstract] [Full Text] [Related]

  • 17. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
    House MG, Kemeny NE, Gönen M, Fong Y, Allen PJ, Paty PB, DeMatteo RP, Blumgart LH, Jarnagin WR, D'Angelica MI.
    Ann Surg; 2011 Dec 01; 254(6):851-6. PubMed ID: 21975318
    [Abstract] [Full Text] [Related]

  • 18. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S, Poston G.
    Colorectal Dis; 2003 Nov 01; 5 Suppl 3():20-8. PubMed ID: 23573557
    [Abstract] [Full Text] [Related]

  • 19. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.
    DʼAngelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N.
    Ann Surg; 2015 Feb 01; 261(2):353-60. PubMed ID: 24646562
    [Abstract] [Full Text] [Related]

  • 20. [Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer].
    Tanaka K, Kumamoto T, Nojiri K, Mori R, Matsuyama R, Takeda K, Ota M, Akiyama H, Ichikawa Y, Endo I.
    Gan To Kagaku Ryoho; 2010 Nov 01; 37(12):2267-70. PubMed ID: 21224543
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.